ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 147 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,215,000 | +185.2% | 23,415 | +310.8% | 0.01% | +150.0% |
| Q4 2021 | $426,000 | +68.4% | 5,700 | +15.7% | 0.00% | -75.0% |
| Q1 2020 | $253,000 | -15.9% | 4,925 | -23.4% | 0.02% | -40.7% |
| Q3 2017 | $301,000 | +4.5% | 6,427 | -31.2% | 0.03% | -6.9% |
| Q1 2017 | $288,000 | -5.0% | 9,336 | -17.9% | 0.03% | -43.1% |
| Q3 2016 | $303,000 | -8.5% | 11,376 | -24.2% | 0.05% | -31.1% |
| Q2 2016 | $331,000 | -7.0% | 15,015 | +24.0% | 0.07% | -49.0% |
| Q1 2016 | $356,000 | – | 12,108 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |